Gattenloehner, Stefan <br/><br/>
Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression.  [electronic resource] 

 -  Blood  Sep 2007 
 - 2027-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-02-074203  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Annexin A5--metabolism<br/>Apoptosis<br/>Blotting, Western<br/>CD56 Antigen--chemistry<br/>Case-Control Studies<br/>Cell Nucleus--genetics<br/>Core Binding Factor Alpha 2 Subunit--genetics<br/>Cytosol--metabolism<br/>Gene Expression Regulation, Leukemic<br/>Gene Library<br/>Genes, Dominant<br/>Humans<br/>Immunoenzyme Techniques<br/>Leukemia, Myeloid--metabolism<br/>Luciferases--metabolism<br/>Muscle Proteins--genetics<br/>NF-kappa B--antagonists & inhibitors<br/>Protein Isoforms<br/>Protein Transport<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>RNA, Small Interfering--pharmacology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Ribonucleases<br/>Tumor Cells, Cultured